Literature DB >> 17673443

A prospective study of breast cancer risk in relatives of BRCA1/BRCA2 mutation carriers.

Erica Rowan, Aletta Poll, Steven A Narod.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17673443      PMCID： PMC2597932     

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  5 in total

1.  Cancer risks in BRCA2 mutation carriers.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1999-08-04       Impact factor: 13.506

2.  Phenocopies in breast cancer 1 (BRCA1) families: implications for genetic counselling.

Authors:  Jacek Gronwald; Cezary Cybulski; Jan Lubinski; Steven A Narod
Journal:  J Med Genet       Date:  2007-04       Impact factor: 6.318

3.  Cancer Incidence in BRCA1 mutation carriers.

Authors:  Deborah Thompson; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

Review 4.  BRCA1 and BRCA2: 1994 and beyond.

Authors:  Steven A Narod; William D Foulkes
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

5.  Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.

Authors:  A Smith; A Moran; M C Boyd; M Bulman; A Shenton; L Smith; R Iddenden; E R Woodward; F Lalloo; E R Maher; D G R Evans
Journal:  J Med Genet       Date:  2006-11-01       Impact factor: 6.318
  5 in total
  12 in total

1.  No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families.

Authors:  Larissa A Korde; Christine M Mueller; Jennifer T Loud; Jeffery P Struewing; Kathy Nichols; Mark H Greene; Phuong L Mai
Journal:  Breast Cancer Res Treat       Date:  2010-05-11       Impact factor: 4.872

2.  No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families.

Authors:  Henriette Roed Nielsen; Janne Petersen; Lotte Krogh; Mef Nilbert; Anne-Bine Skytte
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

3.  Evidence that BRCA1- or BRCA2-associated cancers are not inevitable.

Authors:  Bess Levin; Denise Lech; Bernard Friedenson
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

4.  Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry.

Authors:  Allison W Kurian; Gail D Gong; Esther M John; David A Johnston; Anna Felberg; Dee W West; Alexander Miron; Irene L Andrulis; John L Hopper; Julia A Knight; Hilmi Ozcelik; Gillian S Dite; Carmel Apicella; Melissa C Southey; Alice S Whittemore
Journal:  J Clin Oncol       Date:  2011-10-31       Impact factor: 44.544

Review 5.  Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

Authors:  Dawn C Allain
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

6.  BRCA1 Circos: a visualisation resource for functional analysis of missense variants.

Authors:  Ankita Jhuraney; Aneliya Velkova; Randall C Johnson; Bailey Kessing; Renato S Carvalho; Phillip Whiley; Amanda B Spurdle; Maaike P G Vreeswijk; Sandrine M Caputo; Gael A Millot; Ana Vega; Nicolas Coquelle; Alvaro Galli; Diana Eccles; Marinus J Blok; Tuya Pal; Rob B van der Luijt; Marta Santamariña Pena; Susan L Neuhausen; Talia Donenberg; Eva Machackova; Simon Thomas; Maxime Vallée; Fergus J Couch; Sean V Tavtigian; J N Mark Glover; Marcelo A Carvalho; Lawrence C Brody; Shyam K Sharan; Alvaro N Monteiro
Journal:  J Med Genet       Date:  2015-02-02       Impact factor: 6.318

7.  Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies.

Authors:  Jacopo Azzollini; Chiara Pesenti; Luca Ferrari; Laura Fontana; Mariarosaria Calvello; Bernard Peissel; Giorgio Portera; Silvia Tabano; Maria Luisa Carcangiu; Paola Riva; Monica Miozzo; Siranoush Manoukian
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

8.  Principles of genetic predisposition to malignancies.

Authors:  Tadeusz Debniak; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

9.  No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation-positive families.

Authors:  S Guedaoura; S Pelletier; W D Foulkes; P Hamet; J Simard; N Wong; Z El Haffaf; J Chiquette; M Dorval
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

10.  Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model.

Authors:  Andrew J Lee; Alex P Cunningham; Marc Tischkowitz; Jacques Simard; Paul D Pharoah; Douglas F Easton; Antonis C Antoniou
Journal:  Genet Med       Date:  2016-04-14       Impact factor: 8.822
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.